A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

Vitalité Health Network becomes the first Canadian site to join Breathe BioMedical's multi-center study to advance ...

Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), ...

Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...

For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could dramatically improve survival and quality of life.

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...